Maine Revised Statutes Title 32 Sec. 13833 – Treatment protocol
Current as of: 2023 | Check for updates
|
Other versions
A pharmacist shall administer drugs and vaccines in compliance with a treatment protocol established by a practitioner authorized under the laws of this State to order administration of those drugs and vaccines approved by the board. A copy of the original treatment protocol and any subsequent revisions to the treatment protocol must be kept on the premises of the pharmacy and be available to the board or the board’s representative upon request. At a minimum the treatment protocol must include: [PL 2021, c. 289, §13 (AMD).]
1. Standards. Standards for observation of the person receiving the drug or vaccine to determine whether the person has an adverse reaction, as adopted in rules by the board;
[PL 2011, c. 577, §6 (AMD).]
Terms Used In Maine Revised Statutes Title 32 Sec. 13833
- Board: means the Maine Board of Pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
- Drug: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-APerson: means an individual, corporation, partnership, association or any other legal entity. See Maine Revised Statutes Title 32 Sec. 13702-A Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A Pharmacy: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-APractitioner: means an individual who is licensed, registered or otherwise authorized in the appropriate jurisdiction to prescribe and administer drugs in the course of professional practice. See Maine Revised Statutes Title 32 Sec. 13702-A
2. Procedures. Procedures to be followed by the pharmacist when administering epinephrine or diphenhydramine, or both, to a person who has an adverse reaction to a vaccine administered by the pharmacist; and
[PL 2011, c. 577, §6 (AMD).]
3. Notification. Notification to the authorized practitioner who issued the prescription, standing order or protocol under section 13831, subsection 2 of the administration by the pharmacist of the drug or vaccine, or both, within 3 business days.
[PL 2011, c. 577, §6 (AMD).]
SECTION HISTORY
PL 2009, c. 308, §3 (NEW). PL 2011, c. 577, §6 (AMD). PL 2021, c. 289, §13 (AMD).